S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.53 (+0.28%)
CGC   19.22 (-5.32%)
BABA   187.20 (+0.26%)
T   39.17 (-0.51%)
F   9.05 (-0.33%)
ACB   3.57 (-1.38%)
BAC   33.11 (-0.21%)
DIS   138.57 (+1.34%)
S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.53 (+0.28%)
CGC   19.22 (-5.32%)
BABA   187.20 (+0.26%)
T   39.17 (-0.51%)
F   9.05 (-0.33%)
ACB   3.57 (-1.38%)
BAC   33.11 (-0.21%)
DIS   138.57 (+1.34%)
Log in

Integumen Stock Price, Forecast & Analysis (LON:SKIN)

GBX 1.78
+0.05 (+2.90 %)
(As of 11/12/2019 04:00 PM ET)
Today's Range
Now: GBX 1.78
50-Day Range
MA: GBX 1.75
52-Week Range
Now: GBX 1.78
Volume5.59 million shs
Average Volume41,864 shs
Market Capitalization£17.42 million
P/E RatioN/A
Dividend YieldN/A
Integumen Plc, a personal health care company, develops and commercializes a range of products for oral, skin, and wound care markets. The company develops TS1, a disposable tongue vacuum cleaner for professional use in the dental surgery, a tongue gel, and a handle, which turns the tongue vacuum cleaner into a tongue scraper for home use. It also offers Labskin, a 3-dimensional human skin equivalent model for basic and applied skin research, pre-clinical screening, microbial testing, and efficacy studies of personal care products. In addition, the company provides a range of cosmetic skincare products under the Stoer brand; consumer and professional cosmeceutical products under the Visible Youth brand for anti-ageing; and Clarogel, an over-the-counter cosmetic product for the treatment of blemishes. In addition, it offers Wound pHase, a diagnostic tool, which is used in the acidity/alkalinity of the wound; and hydrogel as a dressing for use in the treatment of burns. The company was incorporated in 2016 and is headquartered in Dalkey, Ireland.

Industry, Sector and Symbol

Industry Household & Personal Products



Sales & Book Value

Annual Sales£567,000.00
Cash FlowGBX 0.10 per share
Book ValueGBX 0.50 per share



Market Cap£17.42 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SKIN News and Ratings via Email

Sign-up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.

Integumen (LON:SKIN) Frequently Asked Questions

What is Integumen's stock symbol?

Integumen trades on the London Stock Exchange (LON) under the ticker symbol "SKIN."

Has Integumen been receiving favorable news coverage?

Media coverage about SKIN stock has been trending very negative on Tuesday, InfoTrie reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Integumen earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Integumen.

Who are some of Integumen's key competitors?

What other stocks do shareholders of Integumen own?

Who are Integumen's key executives?

Integumen's management team includes the folowing people:
  • Mr. Christopher Bell, CFO, Company Sec. & Exec. Director
  • Mr. Donald Nicholson, Exec. Director (Age 61)
  • Mr. Gerard James Brandon, CEO & Director (Age 57)
  • Mr. Camillus Gerard Glover, COO & Director (Age 58)
  • Alex Chapman, Head of Labskin Operations

How do I buy shares of Integumen?

Shares of SKIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Integumen's stock price today?

One share of SKIN stock can currently be purchased for approximately GBX 1.78.

How big of a company is Integumen?

Integumen has a market capitalization of £17.42 million and generates £567,000.00 in revenue each year. Integumen employs 9 workers across the globe.View Additional Information About Integumen.

What is Integumen's official website?

The official website for Integumen is http://www.integumen.co.uk/.

How can I contact Integumen?

Integumen's mailing address is Dalkey, 19 Railway Road, DUBLIN, YO41 1LZ, Ireland. The company can be reached via phone at +353-1-5373269.

MarketBeat Community Rating for Integumen (LON SKIN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about Integumen and other stocks. Vote "Outperform" if you believe SKIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SKIN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Featured Article: What is the Rule of 72?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel